AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 170 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,658,398 | -15.6% | 107,410 | -3.4% | 0.00% | -33.3% |
Q2 2023 | $3,148,419 | +25.7% | 111,173 | +2.0% | 0.01% | +50.0% |
Q1 2023 | $2,504,258 | -19.7% | 109,023 | -1.8% | 0.00% | -33.3% |
Q4 2022 | $3,117,835 | -0.2% | 111,034 | +0.6% | 0.01% | 0.0% |
Q3 2022 | $3,123,000 | +126.8% | 110,420 | +77.8% | 0.01% | +500.0% |
Q2 2022 | $1,377,000 | -14.9% | 62,105 | +11.7% | 0.00% | 0.0% |
Q1 2022 | $1,619,000 | -2.8% | 55,620 | +10.1% | 0.00% | 0.0% |
Q4 2021 | $1,666,000 | -27.2% | 50,500 | +1.8% | 0.00% | -50.0% |
Q3 2021 | $2,290,000 | -16.3% | 49,630 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $2,735,000 | +8.9% | 49,630 | +2.0% | 0.00% | 0.0% |
Q1 2021 | $2,512,000 | -10.2% | 48,640 | -24.6% | 0.00% | -33.3% |
Q4 2020 | $2,797,000 | -5.2% | 64,535 | -23.4% | 0.00% | 0.0% |
Q3 2020 | $2,950,000 | -42.1% | 84,280 | -11.6% | 0.00% | -50.0% |
Q2 2020 | $5,099,000 | +52.1% | 95,332 | +0.9% | 0.01% | +50.0% |
Q1 2020 | $3,353,000 | +11.3% | 94,525 | +49.8% | 0.00% | +33.3% |
Q4 2019 | $3,013,000 | +152.1% | 63,088 | +74.6% | 0.00% | +200.0% |
Q3 2019 | $1,195,000 | -53.8% | 36,134 | -30.4% | 0.00% | -50.0% |
Q2 2019 | $2,588,000 | -30.7% | 51,892 | -6.2% | 0.00% | -50.0% |
Q1 2019 | $3,732,000 | +141.1% | 55,338 | +64.9% | 0.00% | +100.0% |
Q4 2018 | $1,548,000 | -78.5% | 33,562 | -64.0% | 0.00% | -71.4% |
Q3 2018 | $7,192,000 | +88.5% | 93,260 | +105.9% | 0.01% | +75.0% |
Q2 2018 | $3,815,000 | +284.6% | 45,300 | +273.3% | 0.00% | +300.0% |
Q1 2018 | $992,000 | +42.9% | 12,135 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $694,000 | -14.3% | 12,135 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $810,000 | +27.2% | 12,135 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $637,000 | -10.9% | 12,135 | -1.3% | 0.00% | 0.0% |
Q1 2017 | $715,000 | +54.8% | 12,300 | +11.1% | 0.00% | – |
Q4 2016 | $462,000 | -19.5% | 11,074 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $574,000 | +17.6% | 11,074 | -5.1% | 0.00% | 0.0% |
Q2 2016 | $488,000 | +3.2% | 11,669 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $473,000 | -87.0% | 11,669 | -77.3% | 0.00% | -75.0% |
Q3 2015 | $3,635,000 | +38.3% | 51,500 | +117.7% | 0.00% | +33.3% |
Q2 2015 | $2,629,000 | – | 23,655 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |